Clinical Trial Update: Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating urinary versus recombinant FSH in oocyte donors, stratified by FSH receptor N680S polymorphism; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• recombinant FSH (follicle-stimulating hormone)
• urinary FSH

Snippet

Sponsor: Instituto Bernabeu | Conditions: Reproductive Techniques, Assisted | Phase 4 | Status: UNKNOWN